CLU and Alzheimer disease: We investigated plasma levels of AD-relevant complement proteins (C1q, clusterin, sCR1, C1s, FH) in AD patients and controls, and assessed their prediction accuracy in diagnosing AD alongside AT(N) biomarkers.